-
L413798-250mgInformationLDC1267 LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <:5 nM, 8 nM, and 29 nM for Mer, Tyro3, and Axl, respectively. Displays lower activity against Met, Aurora B, Lck, Src, and CDK8.TargetsMer (Cell-free assay): Tyro3
-
L413798-25mgInformationLDC1267 LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <:5 nM, 8 nM, and 29 nM for Mer, Tyro3, and Axl, respectively. Displays lower activity against Met, Aurora B, Lck, Src, and CDK8.TargetsMer (Cell-free assay): Tyro3
-
L413798-5mgInformationLDC1267 LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <:5 nM, 8 nM, and 29 nM for Mer, Tyro3, and Axl, respectively. Displays lower activity against Met, Aurora B, Lck, Src, and CDK8.TargetsMer (Cell-free assay): Tyro3
-
L421370-1mlInformationLDC1267 LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <:5 nM, 8 nM, and 29 nM for Mer, Tyro3, and Axl, respectively. Displays lower activity against Met, Aurora B, Lck, Src, and CDK8.TargetsMer (Cell-free assay): Tyro3
-
L288873-100mgPotent and selective ALK2 inhibitor.
-
L288873-10mgPotent and selective ALK2 inhibitor.
-
L288873-25mgPotent and selective ALK2 inhibitor.
-
L288873-50mgPotent and selective ALK2 inhibitor.
-
L288873-5mgPotent and selective ALK2 inhibitor.
-
L421983-1mlPotent and selective ALK2 inhibitor.
-
L287663-100mgApplication:LE 135 has been used for in vitro islet treatment.
-
L287663-10mgApplication:LE 135 has been used for in vitro islet treatment.